Get started
Author

Kendra M. Gilreath

Observed names: Gilreath, K., Kendra Gilreath, Kendra M Gilreath
ORCID: 0009-0003-8898-527X
Observed ORCID: 0009-0003-8898-527X
OpenAlex ID: A5095964553
Synthesis and Evaluation of 1,3-Disubstituted Imidazolidine-2,4,5-triones as Inhibitors of Pyruvate Carboxylase
2024 · Nicholas O. Schneider, Kendra Gilreath, et al. · ACS Medicinal Chemistry Letters · 5
PDF
Synthesis and Evaluation of 5-(Heteroarylmethylene)hydantoins as Glycogen Synthase Kinase-3β Inhibitors
2024 · Nicholas O. Schneider, Kendra Gilreath, et al. · Pharmaceuticals · 2
Obstruction in Hypertrophic Cardiomyopathy: Don't Forget Midventricular Obstruction
2025 · Kendra M. Gilreath, Jeffrey B. Geske · Journal of the American Society of Echocardiography · 1
Diagnostic value of a subjective functional score among patients with hypertrophic cardiomyopathy
2026 · Ian M. Michel, Kendra M. Gilreath, et al. · BMC Cardiovascular Disorders
Pathogenesis, screening, and diagnosis of hypertrophic cardiomyopathy
2026 · Kendra M Gilreath, Darrell B Newman, et al. · BMJ Medicine
PDF
Risk Factors for Left Atrial Thrombus in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
2026 · Raghav R. Julakanti, Kendra M. Gilreath, et al. · Journal of the American Society of Echocardiography
Abstract 4363343: Papillary Muscle Anatomy in Hypertrophic Cardiomyopathy: Comparison to Normal and Impact on Outcomes of Septal Myectomy
2025 · Kendra Gilreath, Tedy Sawma, et al. · Circulation
Works count: 9
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type